Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks
I. Loubinoux et al., Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks, J CEREBR B, 19(12), 1999, pp. 1365-1375
Fluoxetine inhibits the reuptake of serotonin, and dextroamphetamine enhanc
es presynaptic release of monoamines. Although the excitatory effect of bot
h noradrenaline and dopamine on motor behavior generally is accepted, the r
ole of serotonin on motor output is under debate. In the current investigat
ion, the authors evidenced a putative role of monoamines and, more specific
ally, of serotonin in the regulation of cerebral motor activity in healthy
subjects. The effects on cerebral motor activity of a single dose of fluoxe
tine (20 mg), an inhibitor of serotonin reuptake, and fenozolone (20 mg/50
kg), an amphetamine-like drug, were assessed by functional magnetic resonan
ce imaging. Subjects performed sensorimotor tasks with the right hand. Func
tional magnetic resonance imaging studies were performed in two sessions on
two different days. The first session, with two scan experiments separated
by 5 hours without any drug administration, served as time-effect control.
A second, similar session but with drug administration after the first sca
n assessed drug effects. A large increase in evoked signal intensity occurr
ed in the ipsilateral cerebellum, and a parallel, large reduction occurred
in primary and secondary motor cortices (P < 10(-3)). These results are con
sistent with the known effects of habituation. Both drugs elicited comparab
le effects, that is, a more focused activation in the contralateral sensori
motor area, a greater involvement of posterior supplementary motor area, an
d a widespread decrease of bilateral cerebellar activation (P < 10(-3)). Th
e authors demonstrated for the first time that cerebral motor activity can
be modulated by a single dose of fluoxetine or fenozolone in healthy subjec
ts. Drug effects demonstrated a direct or indirect involvement of monoamine
s and serotonin in the facilitation of cerebral motor activity.